Glutathione S-transferases in pediatric cancer

Frontiers in Oncology

Volumn 1, Issue OCT, 2011, Pages

  Luo, Wen ^a,b   Kinsey, Michelle ^a,b   Schiffman, Joshua D ^a,b   Lessnick, Stephen L ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Drug resistance; Epidemiology; Glutathione S transferase; Microsatellite; Pediatric cancer; Therapeutic target

Indexed keywords

EID: 84879630371     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2011.00039     Document Type: Review

References (110)

1. Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. (1999). Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334.
2. Anderer, G., Schrappe, M., Brechlin, A. M., Lauten, M., Muti, P., Welte, K., and Stanulla, M. (2000). Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics 10, 715-726.
3. Aniya, Y., and Imaizumi, N. (2011). Mitochondrial glutathione transferases involving a new function for membrane permeability transition pore regulation. Drug Metab. Rev. 43, 292-299.
4. Armstrong, R. N. (1997). Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 10, 2-18.
5. Ashton, L. J., Murray, J. E., Haber, M., Marshall, G. M., Ashley, D. M., and Norris, M. D. (2007). Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenet. Genomics 17, 709-717.
6. Bader, P., Fuchs, J., Wenderoth, M., von Schweinitz, D., Niethammer, D., and Beck, J. F. (1998). Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin. Anticancer Res. 18, 3127-3132.
7. Baez, S., Segura-Aguilar, J., Widersten, M., Johansson, A. S., and Mannervik, B. (1997). Glutathione transferases catalyse the detoxication of oxidized metabolites (?-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324, 25-28.
8. Balogh, L. M., Le Trong, I., Kripps, K. A., Shireman, L. M., Stenkamp, R. E., Zhang, W., Mannervik, B., and Atkins, W. M. (2011). Substrate specificity combined with stereopromiscuity in glutathione transferase A4-4-dependent metabolism of 4-hydroxynonenal. Biochemistry 49, 1541-1548.
9. Balta, G., Yuksek, N., Ozyurek, E., Ertem, U., Hicsonmez, G., Altay, C., and Gurgey, A. (2003). Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am. J. Hematol. 73, 154-160.
10. Beck, J., Handgretinger, R., Klingebiel, T., Dopfer, R., Schaich, M., Ehninger, G., Niethammer, D., and Gekeler, V. (1996). Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 10, 426-433.
11. Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B. (1994). Detoxication of base propenals and other α,β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferase. Proc. Natl. Acad. Sci. U.S.A. 91, 1480-1484.
12. Beuckmann, C. T., Fujimori, K., Urade, Y., and Hayaishi, O. (2000). Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem. Res. 25, 733-738.
13. Board, P. G., Coggan, M., Cappello, J., Zhou, H., Oakley, A. J., and Anders, M. W. (2008). S-(4-nitrophenacyl)glutathione is a specific substrate for glutathione transferase omega 1-1. Anal. Biochem. 374, 25-30.
14. Board, P. G., Coggan, M., Chelvanavagam, G., Easteal, S., Jermjin, L. S., Schulte, G. K., Danley, D. E., Hoth, L. R., Griffor, M. C., Kamath, A. V., Rosner, M. H., Chrunvk, B. A., Perregaux, D. E., Gabel, C. A., Geoghegan, K. F., and Pandit, J. (2000). Identification, characterization, and crystal structure of the Omega class glutathione transferases. J. Biol. Chem. 275, 24798-24806.
15. Bolt, H. M., and Their, R. (2006). Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab. 7, 613-628.
16. Booth, J., Boyland, E., and Sims, P. (1961). An enzyme from rat liver catalyzing conjugations with glutathione. Biochem. J. 79, 516-524.
17. Chen, C. L., Liu, Q., Pui, C. H., Rivera, G. K., Sandlund, J. T., Ribeiro, R., Evans, W. E., and Relling, M. V. (1997). Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood 89, 1701-1707.
18. Cho, S. G., Lee, Y. H., Park, H. S., Ryoo, K., Kang, K. W., Park, J., Eom, S. J., Kim, M. J., Chang, T. S., Choi, S. Y., Shim, J., Kim, Y., Dong, M. S., Lee, M. J., Kim, S. G., Ichijo, H., and Choi, E. J. (2001). Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276, 12749-12755.
19. Coles, B., Yang, M., Lang, N. P., and Kadlubar, F. F. (2000). Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. Cancer Lett. 156, 167-175.
20. Coombes, B., and Stakelum, G. S. (1961). A liver enzyme that conjugates sulfobromophthalein with glutathione. J. Clin. Invest. 40, 981-988.
21. Davies, S. M., Bhatia, S., Ross, J. A., Kiffmeyer, W. R., Gaynon, P. S., Radloff, G. A., Robison, L. L., and Perentesis, J. P. (2002). Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100, 67-71.
22. Davies, S. M., Robison, L. L., Buckley, J. D., Radloff, G. A., Ross, J. A., and Perentesis, J. P. (2000). Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol. Biomarkers Prev. 9, 563-566.
23. Davies, S. M., Robison, L. L., Buckley, J. D., Tjoa, T., Woods, W. G., Radloff, G. A., Ross, J. A., and Perentesis, J. P. (2001). Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J. Clin. Oncol. 19, 1279-1287.
24. Di Pietro, G., Magno, L. A., and Rios-Santos, F. (2010). Glutathione S-transferases: an overview in cancer research. Expert Opin. Drug Metab. Toxicol. 6, 153-170.
25. Dorion, S., Lambert, H., and Landry, J. (2002). Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione s-transferase Mu from Ask1. J. Biol. Chem. 277, 30792-30797.
26. Doroshyenko, O., Fuhr, U., Kunz, D., Frank, D., Kinzig, M., Jetter, A., Reith, Y., Lazar, A., Taubert, D., Kirchheiner, J., Baum, M., Eisenbrand, G., Berger, F. I., Bertow, D., Berkessel, A., Sorgel, F., Schomig, E., and Tomalik-Scharte, D. (2009). In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol. Biomarkers Prev. 18, 433-443.
27. Dreij, K., Sundberg, K., Johansson, A. S., Nordling, E., Seidel, A., Persson, B., Mannervik, B., and Jernstrom, B. (2002). Catalytic activities of human alpha class glutathione transferases toward carcinogenic dibenzo[a,l]pyrene diol epoxides. Chem. Res. Toxicol. 15, 825-831.
28. Dulhunty, A. F., Hewawasam, R., Liu, D., Casarotto, M. G., and Board, P. G. (2011). Regulation of the cardiac muscle ryanodine receptor by glutathione transferases. Drug Metab. Rev. 43, 236-252.
29. Economopoulos, K. P., and Sergentanis, T. N. (2010). GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur. J. Cancer 46, 1617-1631.
30. Elsby, R., Kitteringham, N. R., Goldring, C. E., Lovatt, C. A., Chamberlain, M., Henderson, C. J., Wolf, C. R., and Park, B. K. (2003). Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J. Biol. Chem. 278, 22243-22249.
31. Flanagan, J. U., and Smythe, M. L. (2011). Sigma-class glutathione transferases. Drug Metab. Rev. 43, 194-214.
32. Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., and Lessnick, S. L. (2010). Emergent properties of EWS/FLI regulation via GGAA microsatellites in Ewing's sarcoma. Genes Cancer 1, 177-187.
33. Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., and Lessnick, S. L. (2008). Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 105, 10149-10154.
34. Garcia-Aragoncillo, E., Carillo, J., Lalli, E., Agra, N., Gómez-López, G., Pestaña, A., and Alonso, J. (2008). DAX1, a direct target of EWS/FLI oncoprotein, is a principle regulator of cell-cycle progression in Ewing's tumor cells. Oncogene 27, 6034-6043.
35. Gatedee, J., Pakakassama, S., Muangman, S., and Pongstaporn, W. (2007). Glutathione S-transferase P1 genotypes, genetic susceptibility and outcome of therapy in thai childhood acute lymphoblastic leukemia. Asian Pac. J. Cancer Prev. 8, 294-296.
36. Hayes, J. D., and McLellan, L. I. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31, 273-300.
37. Hayes, J. D., and Strange, R. C. (2000). Glutathione s-transferase polymorphisms and their biological consequences. Pharmacology 61, 154-166.
38. Henderson, C. J., and Wolf, C. R. (2011). Knockout and transgenic mice in glutathione transferase research. Drug Metab. Rev. 43, 152-164.
39. Hiley, C., Bell, J., Hume, R., and Strange, R. (1989). Differential expression of alpha and pi isoenzymes of glutathione s-transferase in developing human kidney. Biochim. Biophys. Acta 990, 321-324.
40. Hosono, N., Kishi, S., Iho, S., Urasaki, Y., Yoshida, A., Kurooka, H., Yokota, Y., and Ueda, T. (2010). Glutathione s-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line. Cancer Sci. 101, 767-773.
41. Hu, X., Ji, X., Srivastava, S. K., Xia, H., Awasthi, S., Nanduri, B., Awasthi, Y. C., Zimniak, P., and Singh, S. V. (1997a). Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxides of chrysene. Arch. Biochem. Biophys. 345, 32-38.
42. Hu, X., O'Donnell, R., Srivastava, S. K., Xia, H., Zimniak, P., Nanduri, B., Bleicher, R. J., Awasthi, S., Awasthi, Y. C., Ji, X., and Singh, S. V. (1997b). Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7β,8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo(α)pyrene. Biochem. Biophys. Res. Commun. 235, 424-428.
43. Hu, X., Xia, H., Srivastava, S. K., Herzog, C., Awasthi, Y. C., Ji, X., Zimniak, P., and Singh, S. V. (1997c). Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 238, 397-402.
44. Hu, X., Xia, H., Srivastava, S. K., Pal, A., Awasthi, Y. C., Zimniak, P., and Singh, S. V. (1998). Catalytic efficiencies of allelic variants of human glutathione-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene. Cancer Res. 58, 5340-5343.
45. Huang, C. Y., Huang, K. L., Cheng, T. J., Wang, J. D., and Hsieh, L. L. (1997). The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function. Arch. Toxicol. 71, 482-488.
46. Huang, J. X., Li, F. Y., Xiao, W., Song, Z. X., Qian, R. Y., Chen, P., and Salminen, E. (2009). Expression of thymidylate synthase and glutathione-s-transferase pi in patients with esophageal squamous cell carcinoma. World J. Gastroenterol. 15, 4316-4321.
47. Hubatsch, I., Ridderstrom, M., and Mannervik, B. (1998). Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem. J. 330, 175-179.
48. Jakobsson, P. J., Mancini, J. A., and Ford-Hutchinson, A. W. (1996). Identification and characterization of a novel human microsomal glutathione S-transferase with leukotrience C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase. J. Biol. Chem. 271, 22203-22210.
49. Jakobsson, P. J., Mancini, J. A., Riendeau, D., and Ford-Hutchinson, A. W. (1997). Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities. J. Biol. Chem. 272, 22934-22939.
50. Jazbec, J., Aplenc, R., Dolzan, V., Debeljak, M., and Jereb, B. (2003). GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia. Leukemia 17, 2540-2542.
51. Johansson, A. S., and Mannervik, B. (2001). Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J. Biol. Chem. 276, 33061-33065.
52. Johansson, K., Jarvliden, J., Gogvadze, V., and Morgenstern, R. (2010). Multiple roles of microsomal glutathione transferase 1 in cellular protection: a mechanistic study. Free Radic. Biol. Med. 49, 1638-1645.
53. Johnson, W. W., Ueng, Y. F., Widersten, W., Mannervik, B., Hayes, J. D., Sherratt, P. J., Ketterer, B., and Guengerich, F. P. (1997). Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalysed by rat and human glutathione transferases: estimation of kinetic parameters. Biochemistry 36, 3056-3060.
54. Joseph, T., Kusumakumary, P., Chacko, P., Abraham, A., and Pillai, M. R. (2004). Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr. Blood Cancer 43, 560-567.
55. Josephy, P. D. (2010). Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum. Genomics Proteomics 2010, 876940-876953.
56. Kanaoka, Y., Ago, H., Inagaki, E., Nanayama, T., Miyano, M., Kikuno, R., Fujii, Y., Eguchi, N., Toh, H., Urade, Y., and Hayaishi, O. (1997). Cloning and crystal structure of hematopoietic prostaglandin D synthase. Cell 90, 1085-1095.
57. Kham, S. K., Soh, C. K., Heng, C. K., Ariffin, H., Quah, T. C., and Yeoh, A. E. (2004). Double deletions of glutathione S-transferase genes (GSTM1 and GSTT1) reduce the risk of early relapse in childhood B-lineage acute lymphoblastic leukaemia (ALL). Ann. Acad. Med. Singapore 33, S83-S85.
58. Kinsey, M., Smith, R., and Lessnick, S. L. (2006). NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol. Cancer Res. 4, 851-859.
59. Krajinovic, M., Labuda, D., Richer, C., Karimi, S., and Sinnett, D. (1999). Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93, 1496-1501.
60. Krajinovic, M., Labuda, D., and Sinnett, D. (2002). Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 12, 655-658.
61. Luo, W., Gangwal, K., Sankar, S., Boucher, K. M., Thomas, D., and Lessnick, S. L. (2009). GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Oncogene 28, 4126-4132.
62. Mancini, J. A., Abramovitz, M., Cox, M. E., Wong, E., Charleson, S., Perrier, H., Wang, Z., Prasit, P., and Vickers, P. J. (1993). 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318, 277-281.
63. Mancini, J. A., Blood, K., Guay, J., Gordon, R., Claveau, D., Chan, C. C., and Riendeau, D. (2001). Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis. J. Biol. Chem. 279, 4469-4475.
64. Marino, S., Verzegnassi, F., Tamaro, P., Stocco, G., Bartoli, F., Decorti, G., and Rabusin, M. (2009). Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. Pediatr. Blood Cancer 53, 984-991.
65. McMahon, B. A., Koyner, J. L., and Murray, P. T. (2010). Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review. Curr. Opin. Crit. Care 16, 550-555.
66. McMurtry, V., Saavedra, J. E., Nieves-Alicea, R., Simeone, A. M., Keefer, L. K., and Tari, A. M. (2011). JS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cells. Int. J. Oncol. 38, 963-971.
67. Mileo, A. M., Abbruzzese, C., Mattarocci, S., Bellacchio, E., Pisano, P., Federico, A., Maresca, V., Picardo, M., Giorgi, A., Maras, B., Schininà, M. E., and Paggi, M. G. (2009). Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival. PLoS ONE 4, e7254. doi: 10.1371/journal.pone.0007254
68. Minelli, C., Granell, R., Newson, R., Rose-Zerilli, M. J., Torrent, M., Ring, S. M., Holloway, J. W., Shaheen, S. O., and Henderson, J. A. (2010). Glutathione-S-transferase genes and asthma phenotypes: a human genome epidemiology (HuGE) systematic review and meta-analysis including unpublished data. Int. J. Epidemiol. 39, 539-562.
69. Morgan, A. S., Ciaccio, P. J., Tew, K. D., and Kauvar, L. M. (1996). Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother. Pharmacol. 37, 363-370.
70. Muller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., and Jansen, P. L. (1994). Proc. Natl. Acad. Sci. U.S.A. 91, 13033-13037.
71. Nakamura, Y., Ohigashi, H., Masuda, S., Murakami, A., Morimitsu, Y., Kawamoto, Y., Osawa, T., Imagawa, M., and Uchida, K. (2000). Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates. Cancer Res. 60, 219-225.
72. Norrgard, M. A., and Mannervik, B. (2011). Engineering GST M2-2 for high activity with indene 1,2-oxide and indication of an H-site residue sustaining catalytic promiscuity. J. Mol. Biol. 412, 111-120.
73. Oakley, A. (2011). Glutathione transferases: a structural perspective. Drug Metab. Rev. 43, 138-151.
74. Owen, L. A., and Lessnick, S. L. (2006). Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Cell Cycle 5, 2049-2053.
75. Pakakasama, S., Mukda, E., Sasanakul, W., Kadegasem, P., Udomsubpayakul, U., Thithapandha, A., and Hongeng, S. (2005). Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am. J. Hematol. 79, 202-205.
76. Pasello, M., Manara, M. C., Michelacci, F., Fanelli, M., Hattinger, C. M., Nicoletti, G., Landuzzi, L., Lollini, P. L., Caccuri, A., Picci, P., Scotlandi, K., and Serra, M. (2011). Targeting glutathione-s transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. Anal. Cell. Pathol. (Amst.) 34, 131-145.
77. Pongstaporn, W., Pakakasama, S., Sanguansin, S., Hongeng, S., and Petmitr, S. (2009). Polymorphism of glutathione S-transferase Omega gene: association with risk of childhood acute lymphoblastic leukemia. J. Cancer Res. Clin. Oncol. 135, 673-678.
78. Ricci, G., De Maria, F., Antonini, G., Turella, P., Bullo, A., Stella, L., Filomeni, G., and Caccuri, A. M. (2005). 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione s-transferases. J. Biol. Chem. 280, 26397-26405.
79. Robinson, A., Huttley, G. A., Booth, H. S., and Board, P. G. (2004). Modelling and bioinformatics studies of the human Kappa-class glutathione transferase predict a novel third glutathione transferase family with similarity to prokaryotic 2-hydroxychromene-2-carboxylate isomerases. Biochem. J. 379, 541-552.
80. Romero, L., Andrews, K., Ng, L., O'Rourke, K., Maslen, A., and Kirby, G. (2006). Human GSTA-1 reduces c-Jun N-terminal kinase signaling and apoptosis in Caco-2 cells. Biochem. J. 400, 135-141.
81. Ruzza, P., and Quintieri, L. (2009). Enzymes as useful tools and potential targets in cancer chemotherapy. Anticancer Agents Med. Chem. 9, 716.
82. Sau, A., Pellizzari Tregno, F., Valentino, F., Federici, G., and Caccuri, A. M. (2010). Glutathione transferases and development of new principles to overcome drug resistance. Arch. Biochem. Biophys. 500, 116-122.
83. Sauerbrey, A., Zintl, F., and Volm, M. (1994). P-glycoprotein and glutathione S-transferase pi in childhood acute lymphoblastic leukaemia. Br. J. Cancer 70, 1144-1149.
84. Schaefer, K. L., Eisenacher, M., Braun, Y., Brachwitz, K., Wai, D. H., Dirksen, U., Lanvers-Kaminsky, C., Juergens, H., Herrero, D., Stegmaier, S., Koscielniak, E., Eggert, A., Nathrath, M., Gosheger, G., Schneider, D. T., Bury, C., Diallo-Danebrock, R., Ottaviano, L., Gabbert, H. E., and Poremba, C. (2008). Microarray analysis of Ewing's sarcoma family of tumors reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur. J. Cancer 44, 699-709.
85. Schaffert, C. S. (2011). Role of MGST1 in reactive intermediate-induced injury. World J. Gastroenterol. 17, 2552-2557.
86. Scotlandi, K., Remondini, D., Castellani, G., Manara, M. C., Nardi, F., Cantiani, L., Francesconi, M., Mercuri, M., Caccuri, A. M., Serra, M., Knuutila, S., and Picci, P. (2009). Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J. Clin. Oncol. 27, 2209-2216.
87. Seitz, G., Bonin, M., Fuchs, J., Poths, S., Ruck, P., Warmann, S. W., and Armeanu-Ebinger, S. (2010). Inhibition of glutathione-s-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma. Int. J. Oncol. 36, 491-500.
88. Shami, P. J., Saavedra, J. E., Bonifant, C. L., Chu, J., Udupi, V., Malaviya, S., Carr, B. I., Kar, S., Wang, M., Jia, L., Ji, X., and Keefer, L. K. (2006). Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo. J. Med. Chem. 49, 4356-4366.
89. Sherratt, P. J., Pulford, D. J., Harrison, D. J., Green, T., and Hayes, J. D. (1997). Evidence that human class theta glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GSTT1 with that of classes alpha, mu and pi GST in human. Biochem. J. 326, 837-846.
90. Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., and Lessnick, S. L. (2006). Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9, 405-416.
91. Stanulla, M., Schrappe, M., Brechlin, A. M., Zimmermann, M., and Welte, K. (2000). Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 95, 1222-1228.
92. Strange, R. C., Howie, A. F., Hume, R., Matharoo, B., Bell, J., Hiley, C., Jones, P., and Beckett, G. J. (1989). The development expression of alpha-, mu-and pi-class glutathione s-transferases in human liver. Biochem. Biophys. Acta 993, 186-190.
93. Takanashi, M., Morimoto, A., Yagi, T., Kuriyama, K., Kano, G., Imamura, T., Hibi, S., Todo, S., and Imashuku, S. (2003). Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica 88, 1238-1244.
94. Tan, K. L., Chelyanayagam, G., Parker, M. W., and Board, P. G. (1996). Mutagenesis of the active site of the human Theta-class glutathione transferase GSTT2-2: catalysis with different substrates involves different residues. Biochem. J. 319, 315-321.
95. Tanaka-Kagawa, T., Jinno, H., Hasegawa, T., Makino, Y., Seko, Y., Hanjoka, N., and Ando, M. (2003). Functional characterization of two variant human GSTO1-1s (Ala40Asp and Thr217Asn). Biochem. Biophys. Res. Commun. 301, 516-520.
96. Tew, K. D., Dutta, S., and Schultz, M. (1997). Inhibitors of glutathione S-transferases as therapeutic agents. Adv. Drug Deliv. Rev. 26, 91-104.
97. Tew, K. D., Manevich, Y., Grek, C., Xiong, Y., Uys, J., and Townsend, D. M. (2011). The role of glutathione s-transferase P in signaling pathways and s-glutathionylation in cancer. Free Radic. Biol. Med. 51, 299-313.
98. Tew, K. D., Monks, A., Barone, L., Rosser, D., Akerman, G., Montali, J. A., Wheatley, J. B., and Schmidt, D. E. (1996). Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol. Pharmacol. 50, 149-159.
99. Timofeeva, M., Jager, B., Rosenberger, A., Sauter, W., Wichmann, H. E., KORA Study Group, Bickeboller, H., and Risch, A. (2009). A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers. Clin. Biochem. 42, 500-509.
100. Tirado, O. M., Mateo-Lozano, S., Villar, J., Dettin, L. E., Llort, A., Gallego, S., Ban, J., Kovar, H., and Notario, V. (2006). Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res. 66, 9937-9947.
101. Tong, Z., Board, P. G., and Anders, M. W. (1998a). Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331, 371-374.
102. Tong, Z., Board, P. G., and Anders, M. W. (1998b). Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other a-haloacids. Chem. Res. Toxicol. 11, 1332-1338.
103. Townsend, D. M., and Tew, K. D. (2003). The role of glutathione-s-transferase in anti-cancer drug resistance. Oncogene 22, 7369-7375.
104. Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., Philip, T., Lenoir, G. M., and Mazabraud, A. (1988). Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet. Cytogenet. 32, 229-238.
105. Turella, P., Cerella, C., Filomeni, G., Bullo, A., De Maria, F., Ghibelli, L., Ciriolo, M. R., Cianfriglia, M., Mattei, M., Federici, G., Ricci, G., and Caccuri, A. M. (2005). Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res. 65, 3751-3761.
106. Turella, P., Filomeni, G., Dupuis, M. L., Ciriolo, M. R., Molinari, A., De Maria, F., Tombesi, M., Cianfriglia, M., Federici, G., Ricci, G., and Caccuri, A. M. (2006). A strong glutathione s-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells: NBDHEX triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells. J. Biol. Chem. 281, 23725-23732.
107. Wondrak, G. T. (2009). Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid. Redox Signal. 11, 3013-3069.
108. Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S., Jiang, Y., and Yin, Z. (2006). Human glutathion s-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25, 5787-5800.
109. Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., Beckett, G. J., Wathen, C. G., Wolf, C. R., and Spurr, N. K. (1991). Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12, 1533-1537.
110. Zielinska, E., Zubowska, M., and Bodalski, J. (2004). Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr. Blood Cancer 43, 552-559.